Anthropic says Claude aided early drug work with six partners
Reported lab results include a CAR-T design about 70% shorter and about 35,000 antibody designs.
50
- Mentions · 7d0
- Mentions · 30d1
- All mentions2
- First seenSep 23, 2026
- Last mentioned15d ago
Timeline
2 articles · newest firstEnveda secures $311M to bring more nature-derived AI drugs into clinical trials
Enveda raised a $311 million Series E at a $2 billion valuation to advance AI-discovered, nature-derived drugs into trials.
48
Appears with
- The Column Grouporganization · 1
- Catalio Capital Managementorganization · 1
- BigHat Biosciencesorganization · 1
- Recursion Pharmaceuticalsorganization · 1
- Bristol Myers Squibborganization · 1
- Anthropicorganization · 1
- Claudeai model · 1
- Iconiqorganization · 1
- Divergence Labsorganization · 1
- Generate Biomedicinesorganization · 1
Entities are extracted by the model from each article. First seen , last mentioned . Watching keeps it in this browser only (no account); the watchlist page and dashboard alerts use it.